Search

Your search keyword '"McNicholl, I"' showing total 21 results

Search Constraints

Start Over You searched for: Author "McNicholl, I" Remove constraint Author: "McNicholl, I"
21 results on '"McNicholl, I"'

Search Results

1. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

2. Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium

3. A phase 3b open-label pilot study to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) single tablet regimen (STR) in virologically suppressed HIV-1 infected adults harbouring the NRTI resistance mutation M184V and/or M184I (GS-US-292-1824)

4. A phase 3b, open-label, pilot study to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in virologically-suppressed HIV-1 infected adult subjects harboring the NRTI resistance mutation M184V and/or M184I (GS-US-292-1824)

5. EVG/COBI/FTC/TAF Bioequivalence Comparing Whole Tablets with Tablets Dissolved in Tap Water.

6. Bioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: the SOLUBIC randomized crossover study.

7. High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I.

8. Pilot comparison of the ease of swallowing of single tablet antiretroviral regimens.

9. Brief Report: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials.

10. Differential detection of M184V/I between plasma historical HIV genotypes and HIV proviral DNA from PBMCs.

11. Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trial.

12. Analysis of drug-drug interactions among patients receiving antiretroviral regimens using data from a large open-source prescription database.

13. Drug Interactions with Cobicistat- or Ritonavir-Boosted Elvitegravir.

14. Perinatal transmission of multidrug-resistant HIV-1 despite viral suppression on an enfuvirtide-based treatment regimen.

15. Neuraminidase inhibitors: zanamivir and oseltamivir.

16. Malaria epidemiology and economics in a pharmacist-managed international travel clinic.

17. Antiinfectives update: focus on treatment and prevention of viral and associated infections.

18. Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections.

19. Active immunization in HIV-infected patients.

20. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart.

21. Mitoxantrone in pleural effusions.

Catalog

Books, media, physical & digital resources